NCT00375895: Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation |
|
|
| Terminated | 3 | 11 | Europe | ciclosporin, CsA, Cyclosporin | Rennes University Hospital, Novartis | Chronic Hepatitis C, Evidence of Liver Transplantation | 10/08 | 12/09 | | |
2011-000088-28: A Randomized Phase III Study to Determine the Most Promising Postgrafting Immunosuppression for Prevention of Acute GVHD after Unrelated Donor Hematopoietic Cell Transplantation using Nonmyeloablative Conditioning for Patients with Hematologic Malignancies A Multi-Center Trial |
|
|
| Ongoing | 3 | 300 | Europe | Sirolimus, Mycophenolatmofetil, Cyclosporine, EU/1/01/171/007, EU/1/01/171/001, EU/1/96/005/001, EU/1/96/005/004, EU/1/96/005/005, Coated tablet, Oral liquid, Capsule, Tablet, Powder for concentrate for solution for infusion, Capsule, soft, Oral suspension, Concentrate and solvent for concentrate for solution for infusion, Rapamune, CellCept, Sandimmun | Fred Hutchinson Cancer Research Center | Graft versus host disease, Graft versus host disease is a process where donor cells may react against cells of your body causing inflammation that can involve the skin, liver and gastrointestinal system., Not possible to specify | | | | |
NCT04979884: Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital |
|
|
| Completed | 3 | 102 | RoW | cyclosporine, interleukin-2 | Alexandria University, Science and Technology Development Fund (STDF), ,Egypt | COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Pulmonary Fibrosis | 09/22 | 12/22 | | |
